LIAISON® Calprotectin for the prediction of relapse in quiescent ulcerative colitis: The EuReCa study
Sign Up to like & getrecommendations! Published in 2022 at "United European Gastroenterology Journal"
DOI: 10.1002/ueg2.12268
Abstract: Abstract Introduction Fecal calprotectin (FC) is established as a diagnostic marker to differentiate between inflammatory bowel diseases and non‐inflammatory conditions. Furthermore, it may be effective in monitoring response to treatment, and to predict relapse during… read more here.
Keywords: quiescent ulcerative; relapse; liaison calprotectin; ulcerative colitis ... See more keywords